NICE backs targeted breast cancer therapy
Cost regulators for National Health Service treatments in England and Wales are backing controlled use of targeted breast cancer radiotherapy treatment alongside further research.
Read More
Tag: Intrabeam
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
